Li Guo-Liang, Wang Peng-Long, Xu Xin, Lin Jin-Xuan, Chu Fu-Hao, Song Ji-Xiang, Zhou Shen, Wang Mi-Na, Zhang Yu-Zhong, Lei Hai-Min
Zhongguo Zhong Yao Za Zhi. 2014 Jul;39(14):2679-83.
Ligustrazine, one of the major effective components of the Chinese traditional medicinal herb Ligusticum Chuanxiong Hort, has been reported plenty of biological activities, such as protect cardiovascular and cerebrovascular, neuroprotection and anti-tumor, et al. Because of its remarkable effects, studies on structural modification of ligustrazine have attracted much attention. Ligustrazine synthetic derivatives reported in recent decades are mainly derived from four primary intermediates (TMP-COOH, TMP-OH, TMP-NH2, HO-TMP-OH). To explore the neuroprotection activitiy of ligustrazine intermediates, six ligustrazine intermediates (2, 5, 8, 11, 12, 13) were synthesized and their protective effects against CoCl2-induced neurotoxicity in differentiated PC12 cells were studied. The target compounds were prepared via different chemical methods, including oxidation, substitution, esterification and amidation without changing the structure nucleus of ligustrazine. Compared with TMP (EC50 = 56.03 micromol x L(-1)), four compounds (2, 5, 12 and 13) exhibited higher activity (EC50 < 50 micromol x L(-1)) respectively, of which, compound 2 displayed the highest protective effect against the damaged PC12 cells (EC50 = 32.86 micromol x L(-1)), but target compounds 8 and 11 appeared lower activity (EC50 > 70 micromol x L(-1)). By structure-activity relationships analysis, the introduction of carboxyl, amino to the side chain of ligustrazine and appropriately increase the proportion of ligustrazine may contribute to enhance its neuroprotective activity, which provides a reference for the design, synthesis and activity screening of relevant series of ligustrazine derivatives in the future.
川芎嗪是传统中药材川芎的主要有效成分之一,已报道具有多种生物学活性,如保护心脑血管、神经保护和抗肿瘤等。因其显著的作用,对川芎嗪结构修饰的研究备受关注。近几十年来报道的川芎嗪合成衍生物主要来源于四种主要中间体(TMP-COOH、TMP-OH、TMP-NH2、HO-TMP-OH)。为了探索川芎嗪中间体的神经保护活性,合成了六种川芎嗪中间体(2、5、8、11、12、13),并研究了它们对CoCl2诱导的分化PC12细胞神经毒性的保护作用。目标化合物通过不同的化学方法制备,包括氧化、取代、酯化和酰胺化,而不改变川芎嗪的结构核心。与TMP(EC50 = 56.03 μmol·L(-1))相比,四种化合物(2、5、12和13)分别表现出更高的活性(EC50 < 50 μmol·L(-1)),其中化合物2对受损PC12细胞的保护作用最高(EC50 = 32.86 μmol·L(-1)),但目标化合物8和11的活性较低(EC50 > 70 μmol·L(-1))。通过构效关系分析,在川芎嗪侧链引入羧基、氨基并适当增加川芎嗪的比例可能有助于增强其神经保护活性,这为未来相关系列川芎嗪衍生物的设计、合成和活性筛选提供了参考。